An introduction to Interferon beta-1b
Interferon beta-1b is a specific treatment for Multiple Sclerosis approved for the treatment of patients patients:
- with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis
- with relapsing remitting multiple sclerosis and two or more relapses within the last two years.
- patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.
These pages review the main features of this important product and look into the history of its development.
